165 related articles for article (PubMed ID: 22910222)
1. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.
Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH
Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
Jeon SY; Park JS; Yang HN; Woo DG; Park KH
Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
[TBL] [Abstract][Full Text] [Related]
3. Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles.
Park JS; Yang HN; Woo DG; Jeon SY; Do HJ; Lim HY; Kim JH; Park KH
Biomaterials; 2011 May; 32(14):3679-88. PubMed ID: 21333351
[TBL] [Abstract][Full Text] [Related]
4. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis.
Kim JH; Park JS; Yang HN; Woo DG; Jeon SY; Do HJ; Lim HY; Kim JM; Park KH
Biomaterials; 2011 Jan; 32(1):268-78. PubMed ID: 20875683
[TBL] [Abstract][Full Text] [Related]
5. Multilineage differentiation of human-derived dermal fibroblasts transfected with genes coated on PLGA nanoparticles plus growth factors.
Park JS; Yang HN; Woo DG; Jeon SY; Park KH
Biomaterials; 2013 Jan; 34(2):582-97. PubMed ID: 23092860
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
7. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
[TBL] [Abstract][Full Text] [Related]
8. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
9. [Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts].
Jiang LD; Wang HZ; Zhao FD; Guo JS; Bao CD; Zou HJ; Wang JY
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2925-8. PubMed ID: 18261308
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
11. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
12. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
13. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
te Boekhorst BC; Jensen LB; Colombo S; Varkouhi AK; Schiffelers RM; Lammers T; Storm G; Nielsen HM; Strijkers GJ; Foged C; Nicolay K
J Control Release; 2012 Aug; 161(3):772-80. PubMed ID: 22580113
[TBL] [Abstract][Full Text] [Related]
14. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
16. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
[TBL] [Abstract][Full Text] [Related]
17. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.
Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P
Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells.
Jeon SY; Park JS; Yang HN; Lim HJ; Yi SW; Park H; Park KH
Biomaterials; 2014 Sep; 35(28):8236-48. PubMed ID: 24965885
[TBL] [Abstract][Full Text] [Related]
19. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.
Présumey J; Salzano G; Courties G; Shires M; Ponchel F; Jorgensen C; Apparailly F; De Rosa G
Eur J Pharm Biopharm; 2012 Nov; 82(3):457-64. PubMed ID: 22922428
[TBL] [Abstract][Full Text] [Related]
20. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
